옴니앱(OABI)는 NAS에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $4.47 (+0.68%), 시가총액 $291.39M.
OmniAb, Inc., a biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada. The company's technology platform creates and screens diverse antibody repertoires to identify optimal antibodies and other target-binding proteins for partners' drug development efforts. Its OmniAb platform's Biological Intelligence powers the immune systems of its proprietary and engineered transgenic animals to create optimized antibody candidates for human therapeutics.
옴니앱의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 XTS에서 실시간으로 확인할 수 있습니다.
옴니앱의 현재 주가는 $4.47 (+0.68%)입니다. XTS에서 실시간 시세와 차트를 확인할 수 있습니다.
옴니앱의 시가총액은 약 $291.39M입니다.
OmniAb, Inc., a biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United…